Contact DMCA Privacy

Robuta

https://www.mdpi.com/2077-0383/11/4/1038
Pathologic Complete Response in Urothelial Carcinoma Patients Receiving Neoadjuvant Immune...
Background. Immune checkpoint inhibitors (ICIs) have been evaluated as neoadjuvant treatment in urothelial carcinoma (UC) patients, with these agents reporting...
complete responseurothelial carcinomapathologicpatientsreceiving